Severe recurrent Still's disease requiring IL-1 receptor antagonist treatment in a 17 old woman

被引：0
|
作者：
Schneeberger, D. [1 ]
Devaud, E. [2 ]
Ruffieux, C. [3 ]
Grognuz, F. [1 ]
Spertini, F. [4 ]
机构：
[1] Cabinet Prive, Fribourg, Switzerland
[2] Cabinet Prive, Givisiez, Switzerland
[3] Cabinet Prive, Villars Sur Glane, Switzerland
[4] CHUV, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2008年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：59S / 59S
页数：1
相关论文
共 50 条
  • [31] MUCOSAL IMBALANCE OF IL-1 AND IL-1 RECEPTOR ANTAGONIST IN INFLAMMATORY BOWEL-DISEASE - A NOVEL MECHANISM OF CHRONIC INTESTINAL INFLAMMATION
    CASINIRAGGI, V
    KAM, L
    CHONG, YJT
    FIOCCHI, C
    PIZARRO, TT
    COMINELLI, F
    JOURNAL OF IMMUNOLOGY, 1995, 154 (05): : 2434 - 2440
  • [32] Induction of IL-1 receptor antagonist by interferon beta: implication for the treatment of multiple sclerosis
    Sciacca, FL
    Canal, N
    Grimaldi, LME
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S33 - S37
  • [33] IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice
    Ali, Abukar
    Na, Manli
    Svensson, Mattias N. D.
    Magnusson, Malin
    Welin, Amanda
    Schwarze, Jan-Christoph
    Mohammad, Majd
    Josefsson, Elisabet
    Pullerits, Rille
    Jin, Tao
    PLOS ONE, 2015, 10 (07):
  • [34] Unraveling the pathophysiology of neonatal onset mutisystem inflammatory disease (NOMID/CINCA) by blocking IL-1 with the IL-1 receptor antagonist ANAKINRA
    Goldbach-Mansky, R
    Canna, S
    Dailey, N
    Gelabert, A
    Rubin, B
    Kim, J
    Brewer, C
    Butman, J
    Turner, M
    Karp, B
    Hill, S
    Aksentijevich, I
    Haverkamp, M
    Holland, S
    Hoffman, S
    Pham, TH
    Hawkins, P
    Kastner, DL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 72 - 72
  • [35] Pre-and post-treatment serum levels of cytokines IL-1β, IL-6, and IL-1 receptor antagonist in celiac disease.: Are they related to the associated osteopenia?
    Fornari, MC
    Pedreira, S
    Niveloni, S
    González, D
    Diez, RA
    Vázquez, H
    Mazure, R
    Sugai, E
    Smecuol, E
    Boerr, L
    Mauriño, E
    Bai, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03): : 413 - 418
  • [36] IL-1 Trap rilonacept in refractory adult onset Still's disease
    Petryna, Olga
    Cush, J. Jack
    Efthimiou, Petros
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) : 2056 - 2057
  • [37] IL-1 AND IL-1 RECEPTOR ANTAGONIST (IL-1RA) SYNTHESIS IN THE INTESTINAL-MUCOSA OF INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS
    COMINELLI, F
    FIOCCHI, C
    EISENBERG, SP
    CLINICAL RESEARCH, 1992, 40 (01): : A96 - A96
  • [38] IL-1 Receptor Antagonist Treatment Attenuates Liver Steatosis and Inflammation in Alcoholic Liver Disease: The Role of Inflammasome Activation and IL-1β-Mediated Hepatocyte Steatosis and Cytotoxicity
    Petrasek, Jan
    Dolganiuc, Angela
    Kodys, Karen
    Kurt-Jones, Evelyn A.
    Szabo, Gyongyi
    GASTROENTEROLOGY, 2011, 140 (05) : S887 - S887
  • [39] IL-1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion in a Chinese Han population
    Dai, M. Z.
    Pan, Y. Q.
    Xu, D. P.
    Chen, X. J.
    Qian, R. J.
    Chen, D. H.
    Cui, T. W.
    Lin, A.
    Yan, W. H.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2010, 37 (05) : 393 - 396
  • [40] The role of TNFα and IL-17 in the development of excess IL-1 signaling-induced inflammatory diseases in IL-1 receptor antagonist-deficient mice
    Ishigame, H
    Nakajima, A
    Saijo, S
    Komiyama, Y
    Nambu, A
    Matsuki, T
    Nakae, S
    Horai, R
    Kakuta, S
    Iwakura, Y
    CYTOKINES AS POTENTIAL THERAPEUTIC TARGETS FOR INFLAMMATORY SKIN DISEASES, 2006, 56 : 129 - +
12345